BioPorto Statistics

Total Valuation

BioPorto has a market cap or net worth of DKK 618.71 million. The enterprise value is 570.23 million.

Market Cap	618.71M
Enterprise Value	570.23M

Important Dates

The last earnings date was Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

BioPorto has 429.66 million shares outstanding. The number of shares has increased by 13.18% in one year.

Current Share Class	n/a
Shares Outstanding	429.66M
Shares Change (YoY)	+13.18%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	0.33%
Float	429.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.12
PB Ratio	9.13
P/TBV Ratio	9.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.36
EV / Sales	15.73
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.79

Financial Position

The company has a current ratio of 4.12, with a Debt / Equity ratio of 0.17.

Current Ratio	4.12
Quick Ratio	3.77
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	-0.13
Interest Coverage	-166.55

Financial Efficiency

Return on equity (ROE) is -106.68% and return on invested capital (ROIC) is -64.43%.

Return on Equity (ROE)	-106.68%
Return on Assets (ROA)	-50.75%
Return on Invested Capital (ROIC)	-64.43%
Return on Capital Employed (ROCE)	-99.77%
Revenue Per Employee	755,063
Profits Per Employee	-1.42M
Employee Count	48
Asset Turnover	0.39
Inventory Turnover	2.78

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.92% in the last 52 weeks. The beta is 1.05, so BioPorto's price volatility has been similar to the market average.

Beta (5Y)	1.05
52-Week Price Change	+9.92%
50-Day Moving Average	1.48
200-Day Moving Average	1.81
Relative Strength Index (RSI)	47.67
Average Volume (20 Days)	380,584

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioPorto had revenue of DKK 36.24 million and -68.24 million in losses. Loss per share was -0.17.

Revenue	36.24M
Gross Profit	24.53M
Operating Income	-75.45M
Pretax Income	-73.74M
Net Income	-68.24M
EBITDA	-74.76M
EBIT	-75.45M
Loss Per Share	-0.17

Full Income Statement

Balance Sheet

The company has 59.66 million in cash and 11.19 million in debt, giving a net cash position of 48.47 million or 0.11 per share.

Cash & Cash Equivalents	59.66M
Total Debt	11.19M
Net Cash	48.47M
Net Cash Per Share	0.11
Equity (Book Value)	67.78M
Book Value Per Share	0.16
Working Capital	63.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -83.58 million and capital expenditures -350,000, giving a free cash flow of -83.93 million.

Operating Cash Flow	-83.58M
Capital Expenditures	-350,000
Free Cash Flow	-83.93M
FCF Per Share	-0.20

Full Cash Flow Statement

Margins

Gross margin is 67.68%, with operating and profit margins of -208.17% and -188.29%.

Gross Margin	67.68%
Operating Margin	-208.17%
Pretax Margin	-203.47%
Profit Margin	-188.29%
EBITDA Margin	-206.27%
EBIT Margin	-208.17%
FCF Margin	n/a

Dividends & Yields

BioPorto does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.18%
Shareholder Yield	-13.18%
Earnings Yield	-11.03%
FCF Yield	-13.57%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioPorto has an Altman Z-Score of 9.26.

Altman Z-Score	9.26
Piotroski F-Score	n/a